This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana's (HUM) Alliances to Offer Relief to Members With CKD
by Zacks Equity Research
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
by Sapna Bagaria
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
Why Is Humana (HUM) Up 9.5% Since Last Earnings Report?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Select Medical (SEM) Stock Looks Attractive
by Sapna Bagaria
Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.
UnitedHealth (UNH) Provides Guidance for 2020, Shares Fall
by Sapna Bagaria
UnitedHealth's (UNH) guidance for 2020 indicates revenue and earnings growth but it is believed to be conservative, leading to a decline in shares.
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
by Zacks Equity Research
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
Humana (HUM) vs. Anthem (ANTM): Which is Better Placed?
by Zacks Equity Research
Humana (HUM) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On a comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.
Humana, Epione Tie Up to Aid Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) inks deal with Epione Health of Oklahoma to provide better patient care.
UnitedHealth Group to Enhance its Medicare Advantage Network
by Zacks Equity Research
UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.
3 Healthcare Stocks to Counter Tech Encroachment
by Sreyoshi Mukherjee
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.
Humana (HUM) to Boost Medicare Advantage Network in Hawaii
by Zacks Equity Research
Humana (HUM) teams up with Hawaii Senior Medical Group to enrich patient experience of Medicare Advantage members in the region.
Humana (HUM) Scales New 52-Week High on Solid Q3 Earnings
by Zacks Equity Research
Humana (HUM) reaches a 52-week high, backed by strong-third-quarter results and Medicare business.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
Humana's (HUM) Q3 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter results reflect higher revenues as well as solid membership growth.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6%
by Mark Vickery
To see a negative headline read on U.S. Productivity is thankfully quite rare. The last time we saw this was nearly 4 full years ago.
Humana (HUM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 9.83% and 0.55%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More
by Zacks Equity Research
Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.
What's in the Offing for Humana's (HUM) Earnings in Q3?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to reflect rise in expenses and a negative impact from seasonality on its bottom line.
Humana (HUM) Reports Next Week: What to Expect
by Zacks Equity Research
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) Q3 Earnings and Revenues Beat, Guidance Up
by Sapna Bagaria
UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.
Humana to Provide Florida's Retirees With Medicare Plans
by Zacks Equity Research
Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.
What's in the Cards for UnitedHealth (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 earnings are expected to be benefited from higher revenues and membership growth.
Humana's New Plans to Complement VA Healthcare Coverage
by Zacks Equity Research
Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.
Humana's (HUM) Medicare Business Aids, High Costs Persist
by Zacks Equity Research
Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.